CDK4 expression in chordoma: A potential therapeutic target.

J Orthop Res 2018 06 22;36(6):1581-1589. Epub 2017 Dec 22.

UCLA Orthopaedic Surgery, Sarcoma Biology Laboratory, 615 Charles E Young Dr. South, Biomedical Sciences Research Building, Room 410, Los Angeles, CA 90095.

Chordomas are rare bone tumors and treatment is commonly based on a combination of surgery and radiotherapy. There is no standard chemotherapy treatment for chordoma. The aim of this study was to determine the expression of cyclin-dependent kinase 4 (CDK4) in chordoma and its therapeutic implications. We evaluated CDK4 expression both in chordoma cell lines and in chordoma tissues. Also, we investigated the functional roles of CDK4 in chordoma cell growth and proliferation. Furthermore, the therapeutic implications of targeting CDK4 in chordoma were evaluated. We found CDK4 highly expressed in chordoma cell lines and in a majority (97.7%) of chordoma tissues. Higher CDK4 expression correlated with metastasis and recurrence of chordoma. Treatment of chordoma cells using CDK4 inhibitor palbociclib could efficiently inhibit chordoma cells growth and proliferation. These data demonstrate that targeting CDK4 may be useful as a novel strategy in the treatment of chordoma. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1581-1589, 2018.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jor.23819DOI Listing
June 2018
10 Reads

Publication Analysis

Top Keywords

chordoma
13
treatment chordoma
12
cdk4 chordoma
12
chordoma cell
12
cdk4 expression
12
cdk4
9
targeting cdk4
8
cell lines
8
chordoma cells
8
growth proliferation
8
chordoma tissues
8
therapeutic implications
8
evaluated cdk4
8
expression chordoma
8
majority 977%
4
lines majority
4
977% chordoma
4
lines chordoma
4
higher cdk4
4
tissues higher
4

Similar Publications